局部用雷帕霉素聚乳酸乙醇酸共聚物缓释微球的制备及释药研究(3)
 |
| 第1页 |
参见附件。
[3]张旭东,郭树忠,李荟元,等.雷帕霉素局部用药在异体复合组织移植中的应用[J].中华实验外科杂志,2007,24:370.
[4]Kapila VP,Pharm D, Robert A,et al.Sirolimus (rapamycin): From the soil of Easter Island to a bright future[J].American Academy of Dermatology,2007,57:1046-1050.
[5]Hoffman AS.The origins and evolution of "controlled" drug delivery systems [J].J Controlled Release,2008,132:153-163.
[6]Jhunjhunwala S,Raimondi G,Thomson AW,et al.Delivery of rapamycin to dendritic cells using degradable microparticles [J].J Controlled Release,2009,133:191-197.
[7]Guo SZ, Han Y, Zhang XD,et al.Human facial allotransplantation:a 2-year follow-up study [J].Lancet,2008,372:631-638.
[8]Madani H,Hettiaratchy S,Clarke A,et al.Immunosuppression in an emerging field of plastic reconstructive surgery: composite tissue allotransplantation [J].J Plast Reconstr Aesth Surg,2008,61:245-249.
[9]EI-Sabrout R,Delaney V,Qadir M,et al.Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients-A single center experience [J].Transplantation Proceedings,2003,35:89-94.
[10]Kumar RS,Peyre CG,Sher LS.Immunosuppression[J].Seminars in Anesthesia, Perioperative Medicine and Pain,2004,23:12-22.
[收稿日期]2009-11-16 [修回日期]2010-02-23
编辑/张惠娟
您现在查看是摘要介绍页，详见PDF附件。